Literature DB >> 29601794

Voxelotor (GBT440) produces interference in measurements of hemoglobin S.

Nicola J Rutherford1, Katie L Thoren2, Zahra Shajani-Yi3, Jennifer M Colby4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29601794     DOI： 10.1016/j.cca.2018.03.032

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN： 0009-8981            Impact factor:   3.786


× No keyword cloud information.
  3 in total

1.  Voxelotor treatment of a patient with sickle cell disease and very severe anemia.

Authors:  Arun S Shet; Laurel Mendelsohn; Julia Harper; David Ostrowski; Eric R Henry; Eveline Gwaabe; Jim Nichols; Abdu I Alayash; William A Eaton; Swee Lay Thein
Journal:  Am J Hematol       Date:  2019-01-08       Impact factor: 10.047

2.  Interactions of an Anti-Sickling Drug with Hemoglobin in Red Blood Cells from a Patient with Sickle Cell Anemia.

Authors:  Michael Brad Strader; Hongying Liang; Fantao Meng; Julia Harper; David A Ostrowski; Eric R Henry; Arun S Shet; William A Eaton; Swee L Thein; Abdu I Alayash
Journal:  Bioconjug Chem       Date:  2019-02-28       Impact factor: 6.069

Review 3.  Research in Sickle Cell Disease: From Bedside to Bench to Bedside.

Authors:  Gabriel Salinas Cisneros; Swee Lay Thein
Journal:  Hemasphere       Date:  2021-06-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.